Target intelligence / Profile preview

Mechanical anti-reflux barrier

Molecular classification
Other
01

Overview

The **mechanical anti-reflux barrier** is a functional anatomical region at the gastroesophageal junction whose primary role is to prevent the backflow (reflux) of stomach contents into the esophagus. This barrier is created by the combined action of the lower esophageal sphincter (LES), the crural diaphragm, and the anatomical flap valve formed by the angle of His[1][5]. Breakdown or dysfunction of this barrier leads to gastroesophageal reflux disease (GERD), a common disorder characterized by heartburn, regurgitation, and esophageal injury[7][5]. While it can be reinforced or restored by surgical procedures (such as fundoplication or placement of devices like LINX or RefluxStop), it is not a discrete molecular entity and thus is not “targeted” by drugs in the conventional sense—rather, it is a structure augmented or manipulated by surgery or devices to restore the body's natural anti-reflux function[3][2][4][6]. **Summary:** The "mechanical anti-reflux barrier" is an anatomical functional concept, not a true molecular target or receptor; therefore, it is not classified as an enzyme, receptor, transporter, or other drug target, and cannot be directly targeted by drugs. Its dysfunction is central to the pathology of GERD, and restoration is the goal of anti-reflux surgery or device therapies[1][2][3][4][5][6][7].

Other names
Anti-reflux barrierGastroesophageal barrierGastroesophageal junction barrierLES-crural diaphragm complex
02

Mechanism of action

Not applicable to drugs (mechanics, not molecular interactions); surgical and device therapies restore or augment the barrier function by anatomical modification or reinforcement[3][2][6].

03

Biological functions

Prevention of gastroesophageal reflux (acts as a physical barrier to gastric contents)Regulation of esophageal and gastric pressure dynamics
04

Disease associations

Gastroesophageal reflux disease (GERD)Hiatal hernia
05

Safety considerations

Surgical correction/augmentation can cause dysphagia, gas-bloat syndrome, inability to belch or vomit, and possible failure of the intervention[6][4].

Beyond the preview

Go deeper on Mechanical anti-reflux barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mechanical anti-reflux barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call